Long-Term Effects of Angiotensin-Converting Enzyme Inhibition on Renal Medullary Neutral Lipid in Spontaneously Hypertensive Rats

    loading  Checking for direct PDF access through Ovid

Abstract

Short-term treatment of young spontaneously hypertensive rats (SHR) with angiotensin-converting enzyme (ACE) inhibitors reduces systolic blood pressure. Renal medullary neutral lipids (RMNLs) have vasodilator properties that may explain the effects of ACE inhibition. We measured RMNL levels of SHR treated between 6 and 10 weeks of age with (1) vehicle, (2) ramipril 1 mg [middle dot] kg-1 [middle dot] d-1, (3) the bradykinin B2 receptor antagonist icatibant 0.5 mg [middle dot] kg-1 [middle dot] d-1, or (4) icatibant 0.5 mg [middle dot] kg-1 [middle dot] d-1 plus ramipril 1 mg [middle dot] kg-1 [middle dot] d (-1). RMNLs were quantified by oil red O fluorescence at 10 and 20 weeks of age. Systolic blood pressure (BP) was measured by tail-cuff plethysmography. Ramipril reduced BP at 10 weeks of age and increased RMNLs compared with controls (0.99 +/- 0.07% versus 0.56 +/- 0.06%, P<0.01). Icatibant alone had no significant effect on RMNLs (0.55 +/- 0.04%) but attenuated the increase in RMNLs by ramipril (0.81 +/- 0.05%). In control SHR, the increase in BP between 10 and 20 weeks of age was associated with a significant increase in RMNLs (0.79 +/- 0.09%). SHR that had received ramipril had significantly lower BP than controls at 20 weeks of age, but RMNL was not significantly different (0.92 +/- 0.10%). Therefore, in young SHR, ACE inhibition increases RMNLs and reduces blood pressure, an effect that appears to depend on bradykinin. The changes in RMNLs at the age of 10 weeks paralleled long-term BP effects and may be involved in setting the BP track in SHR. (Hypertension. 1999;33:1214-1217.)

Related Topics

    loading  Loading Related Articles